Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variation across C-reactive protein and risk of prostate cancer.

The Prostate - 1 Jul 2014

Markt Sarah C, Rider Jennifer R, Penney Kathryn L, Schumacher Fredrick R, Epstein Mara M, Fall Katja, Sesso Howard D, Stampfer Meir J, Mucci Lorelei A

Abstract excerpt

BACKGROUND: Inflammation has been hypothesized to play an important etiological role in the initiation or progression of prostate cancer. Circulating levels of the systemic inflammation marker C-reactive protein (CRP) have been associated with increased risk of prostate cancer. We investigated the role of genetic variation in CRP and prostate cancer, under the hypothesis that variants may alter risk of disease....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to C-Reactive Protein

Share to Case-Control Studies

Share to Genetic Variation

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 24844401
DOI: 10.1002/pros.22820
PMCID: PMC4063346

Genes

CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variation across C-reactive protein and risk of prostate cancer.PMID 24844401Read ↗

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.Semantic proximity Read ↗

C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk.Semantic proximity Read ↗

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.Semantic proximity Read ↗

Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer RiskSemantic proximity Read ↗

Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.Semantic proximity Read ↗

C-reactive protein-associated genetic variants and cancer risk: findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies.Semantic proximity Read ↗

Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.Semantic proximity Read ↗

Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.Semantic proximity Read ↗

Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.Semantic proximity Read ↗

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.Semantic proximity Read ↗

Allelic Heterogeneity at the CRP Locus Identified by Whole-Genome Sequencing in Multi-ancestry Cohorts.Semantic proximity Read ↗

Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.